It’s in the male...

This month… 13 years ago… Three letters changed my life… it wasn’t a doctor that told me… I learned of it by reading a life insurance rejection notice I received in the mail along with my deposit refunded to me. Two weeks later my doctor confirmed what the notice stated.

A new life began with one sentence… a death sentence, it was never.

HIV-Positive and As Sexy As I Want to Be | Tyler Curry →

Now, before we begin, you can go ahead and unravel that tight wad your panties have wound themselves into. This blog post is not intended to promote the transmission of HIV, and in no way is it meant to glamorize HIV/AIDS. Is it even possible to glamorize such an abysmal disease? I think not. But I have noticed that when an HIV-positive man takes a public stance without the “woe is me” pretense, that is the general dissent. Glamorizing HIV would be like trying to Photoshop a picture of the Holocaust: No matter how you manipulate it, the ugliness remains. However, I am not HIV itself, and it’s time that people who are HIV-positive stop wearing the face of the virus as if it were their own.

Sometimes life can deal you a hand that can make you feel like you will never win. Being diagnosed with HIV is just one example. But unlike some other unfavorable traits that we carry in our deck, being HIV-positive can seem like the only card you have to play. READ MORE

Bee Venom Kills HIV: Nanoparticles Carrying Toxin Shown To Destroy Human Immunodeficiency Virus

Can bee venom help combat HIV? According to one new study, it can.

A new study has shown that bee venom can kill the human immunodeficiency virus (HIV).

Researchers at Washington University School of Medicine in St. Louis have demonstrated that a toxin called melittin found in bee venom can destroy HIV by poking holes in the envelope surrounding the virus, according to a news release sent out by Washington University.

Visit Washington University’s website to read more about the study.

Nanoparticles smaller than HIV were infused with the bee venom toxin, explains U.S. News & World Report. A “protective bumper” was added to the nanoparticle’s surface, allowing it to bounce off normal cells and leave them intact. Normal cells are larger than HIV, so the nanoparticles target HIV, which is so small it fits between the bumpers.

“Melittin on the nanoparticles fuses with the viral envelope,” said research instructor Joshua L. Hood, MD, PhD, via the news release. “The melittin forms little pore-like attack complexes and ruptures the envelope, stripping it off the virus.” Adding, “We are attacking an inherent physical property of HIV. Theoretically, there isn’t any way for the virus to adapt to that. The virus has to have a protective coat, a double-layered membrane that covers the virus.”

This revelation can lead to the development of a vaginal gel to prevent the spread of HIV and, it seems, an intravenous treatment to help those already infected. “Our hope is that in places where HIV is running rampant, people could use this gel as a preventive measure to stop the initial infection,” said Hood.

The bee venom HIV study was published on Thursday in the journal Antiviral Therapy, according to U.S. News & World Report.

This study comes on the heels of news that a Mississippi baby with HIV has apparently been cured. The mother was diagnosed with HIV during labor and the baby received a three-drug treatment just 30 hours after birth, before tests confirmed the infant was infected. The child, now 2 years old, has been off medication for about a year and shows no sign of infection.

More than 34 million people are living with HIV/AIDS worldwide, according to amFAR, The Foundation for AIDS Research. Of these, 3.3 million are under the age of 15 years old. Each day, almost 7,000 people contract HIV around the globe.

First documented case of child cured of HIV →

Dr. Deborah Persaud of Johns Hopkins University today described the first documented case of a child being cured of HIV. The landmark findings were announced at the 2013 Conference on Retroviruses and Opportunistic Infections in Atlanta, GA.

READ MORE

They created an HIV resistant cell →

Researchers at Stanford University have created HIV-resistant T-cells, a breakthrough that, if proven successful in humans, could potentially stop the virus from developing into AIDS.

The discovery was announced in Tuesday’s issue of Molecular Therapy, and according to researchers, could replace lifelong drug treatments and protect the immune systems of those infected.

A Stanford press release explained the process:

A new study describes the use of a kind of molecular scissors to cut and paste a series of HIV-resistant genes into T-cells. […] By inactivating a receptor gene and inserting additional anti-HIV genes, the virus was blocked from entering the cells, thus preventing it from destroying the immune system.

HIV works by entering and ultimately killing an individual’s T-cells, leading to a collapse of the immune system. Researchers were quick to point out that the therapy is not a cure for HIV, but rather a method to make patients immune to it.

“Once [a person contracts HIV], they become susceptible to all sorts of infections and cancers, and that’s what kills the patient ultimately–not the virus,” explained the study’s principal researcher, Dr. Matthew Porteus, to The Huffington Post. “So our goal is to build an immune system that is resistant to the virus.”

In theory, Porteus and his team could replace a percentage of a patient’s T-cells with the HIV-resistant cells. As the HIV-sensitive cells would die off, the resistant cells would reproduce, eventually creating an immune system of entirely HIV-resistant cells.

“The body has an incredible way of balancing itself,” explained Porteus. “The virus would have no more cells to infect.”

Currently, doctors use drug therapy to help achieve this affect. But because the HIV virus is notorious for mutating, many patients must take dozens of pills a day for the rest of their lives. Should the gene therapy prove successful, the pills–and their sometimes unbearable side effects–would no longer be necessary.

“If you put one roadblock in front of HIV, it is very good about getting around that,” said Porteus. “What we’ve done in our study is shown that we can add multiple layers of protection, creating what is essentially a complete resistance to HIV.”

The Stanford breakthrough is one of several increasingly positive studies in the fight against HIV. In 2007, researchers in Berlin completed a stem cell transplant on an HIV-positive man that appeared to cure him of the virus. Dubbed the “Berlin Patient,” Timothy Ray Brown is still HIV-free four years later.

“The obvious question is why we don’t we do that for everyone,” said Porteus. He explained that the conditions for such a phenomenon are so rare, that a stem cell cure might not be practical on a large scale.

“But if we can create immune systems that are protected against HIV, you could reach a state where you had a fully-functioning immune system with a low level of HIV infection that wouldn’t cause any problems,” he added.

According to the San Francisco Chronicle, researchers plan to conduct more lab work before starting animal testing. The team hopes to begin testing on humans within the next five years.

Huge Breakthrough In HIV Research Brings Us Closer To A Vaccine →

By Tara Culp-Ressler on Jan 4, 2013 at 2:00 pm

A team of Spanish researchers say they have made an important breakthrough in HIV research, developing a new vaccine against the virus that is significantly more effective than earlier attempts. Advancing vaccine research could eventually eliminate the need for the expensive methods currently used to treat HIV-positive individuals.

Researchers tested the vaccine on randomly selected HIV-positive individuals who were already taking highly active antiretroviral of treatment currently available to combat the virus. They wanted to see if, rather than simply suppressing the effects of the virus with outside treatment, their vaccine could lead the human immune system to coordinate its own defense against HIV — and they succeeded, seeing some subjects’ HIV viral loads drop more than 90 percent after 12 weeks of the trial:

“What we did was give instructions to the immune system so it could learn to destroy the virus, which it does not do naturally,” said Felipe Garcia, one of the scientists in the team at Barcelona University’s Hospital Clinic.

The therapeutic vaccine, a shot that treats an existing disease rather than preventing it, was safe and led to a dramatic drop in the amount of HIV virus detected in some patients, said the study, published Wednesday in Science Translation Medicine. […]

The vaccine allowed patients temporarily to live without taking multiple medicines on a daily basis, which created hardship for patients, could have toxic side-effects over the long term and had a high financial price, the team said.

“This investigation opens the path to additional studies with the final goal of achieving a functional cure — the control of HIV replication for long periods or an entire life without anti-retroviral treatment,” the researchers said in a statement.

The researchers did find that the effectiveness of the vaccination declined after the first year, when patients had to return to their previous HAART treatment. Still, though, they noted this breakthrough is the culmination of seven years of research — and they will spend the next several years working to improve the vaccine even further.

Over the past year, the global community has made significant strides forward in its mission to eradicate the HIV/AIDS epidemic. This latest scientific progress builds upon previous research and policy advances that have contributed to better tests and treatments for HIV, better health care for HIV-positive individuals, and ever-increasinglife expectancy rates for those living with the virus.therapy (HAART) medications, the most scientifically advanced form 

Shit People Say About AIDS (by poz10110)

POZ: Gamers Map HIV Protein Protease in Only Three Weeks →

pozmagazine:

It took online gamers three weeks to map the elusive structure of a retrovirus protein, called a protease, that has baffled scientists for more than a decade. Protease plays a vital role in the way that HIV multiplies. Researchers at the University of Washington used a university-developed program called Foldit that transforms real-world science problems into competitive computer games; in this case, players used their three-dimensional problem-solving tools to build accurate models of the protein. Previous automated attempts at mapping the enzyme had failed. Knowing the structure of protease will help researchers design new antiretroviral drugs that can deactivate proteases, thereby greatly reducing or halting the reproduction of HIV. Click here for more.

W00T! W00T!!